MISAPPLICATION OF THE EPO’S PROBLEM-SOLUTION APPROACH AS A GROUND FOR REJECTING A PATENT INVALIDITY CLAIM
[et_pb_section bb_built=”1″ _builder_version=”3.19.5″][et_pb_row][et_pb_column type=”2_5″][et_pb_image _builder_version=”3.19.5″ src=”https://vidalquadrasramon.com/wp-content/uploads/2020/07/VQR_LAW_NEW29.jpg” /][/et_pb_column][et_pb_column type=”3_5″][et_pb_post_title _builder_version=”3.19.5″ comments=”off” featured_image=”off” author=”off” /][et_pb_text _builder_version=”3.19.5″] BY SONIA SARROCA, NÚRIA …
EVERGREENING STRATEGIES IN THE PHARMACEUTICAL SECTOR: SPANISH COURTS REJECT THE CLAIM OF BREACH OF THE RULES ON DATA AND MARKETING EXCLUSIVITY AS AN ACT OF UNFAIR COMPETITION
[et_pb_section bb_built=”1″ _builder_version=”3.19.5″][et_pb_row][et_pb_column type=”2_5″][et_pb_image _builder_version=”3.19.5″ src=”https://vidalquadrasramon.com/wp-content/uploads/2020/05/VQR_LAW_NEW28.jpg” /][/et_pb_column][et_pb_column type=”3_5″][et_pb_post_title _builder_version=”3.19.5″ comments=”off” featured_image=”off” author=”off” /][et_pb_text _builder_version=”3.19.5″] BY MIGUEL VIDAL-QUADRAS AND …
INSIGHTS
Patents, Patents
Sorafenib: a divergent case, like so many others
General, Trademarks
